raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:314718

Lethal arteriopathy syndrome due to fibulin-4 deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A rare, genetic, vascular disorder characterized by severe aneurysmal dilatation, elongation, and tortuosity of the thoracic aorta, its branches and pulmonary arteries with stenosis at various typical locations, typically resulting in infantile demise. Variable associated features may include cutis laxa, long philtrum with thin vermillion border, hypertelorism, sagging cheeks, arachnodactyly, joint laxity and pectus deformities.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enLethal arteriopathy syndrome due to fibulin-4 deficiency
frSyndrome d'artériopathie létale par déficit en fibuline-4
deLetales Arteriopathie-Syndrom durch Fibulin-4-Mangel
esSíndrome de arteriopatía letal por deficiencia de fibulina-4
itSindrome da arteriopatia letale secondaria al deficit di fibulina-4
nlLetaal arteriopathiesyndroom door fibuline-4-deficiëntie
ptSíndrome de arteriopatia letal devido à deficiência de FBLN4
plZespół śmiertelnej arteriopatii z powodu niedoboru fibuliny-4
csSyndrom letální arteriopatie způsobený deficitem fibulinu-4
ukСиндром летальної артеріопатії, зумовлений дефіцитом фібуліну-4
zh纤维蛋白-4缺乏所致致死性动脉病综合征
trFibulin-4 eksikliğine bağlı letal arteriopati sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM614437NTBTvalidated
ICD-10Q25.8NTBTattributedvalidated
ICD-11LA8B.2YNTBTattributedvalidated
MONDO0017818Evalidated
UMLSC5190604Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
EFEMP2Disease-causing germline mutation(s) inAssessedHGNC:3219ENSG0000017263860463311q13.1EGF-like fibulin extracellular matrix protein 222943132[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families22 casesWorldwideCase(s)Validated22943132[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card